You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction

  • Technology appraisal guidance
  • Reference number: TA73
  • Published:  26 November 2003
  • Last updated:  01 July 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence and interpretation
  • 5 Recommendations for further research
  • 6 Implications for the NHS
  • 7 Implementation and audit
  • 8 Appraisal Committee members and NICE project team
  • 9 Sources of evidence considered by the Committee
  • 10 Detail on criteria for audit of the use of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction
  • Update information

5 Recommendations for further research

5.1

Further research is recommended in patients with established CAD regarding the value of SPECT relative to other tests of cardiac function such as echocardiography, magnetic resonance imaging and positron emission tomography in order to inform future assessment of the needs of the NHS.


Next page 6 Implications for the NHS Previous page 4 Evidence and interpretation
Back to top